• Lineage Announces Exclusive Option Agreement With Amasa Therapeutics for Supply and Use of Clinical-Grade Hystem®

    1 month ago - By San Diego Biotechnology

    CARLSBAD, Calif.--- $LCTX LineageCell-Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced it granted an exclusive option to Amasa Therapeutics, Inc. , a privately-held biopharmaceutical company focused on the development of novel cell-based targeted biological...
    Read more ...